Drugs / Betamethason Sodium Phosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04210739 | Jul 2020 → Jul 2021 | chronic prostatitis | Cairo University | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT03054610 Comparator | Jan 2015 → Mar 2020 | plantar fasciitis, salivary substance, Clostridium botulinum type | Autonomous University of Nuevo León | Completed | No outcome recorded |
| Phase 4 | NCT03783182 Comparator | Sep 2019 → Jun 2025 | hemorrhagic disease | Umeå University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Betamethason Sodium Phosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03054610 ↗ |
| Route | Other | “intralesional steroids” NCT03054610 ↗ |